Canaccord Genuity Reiterates Buy Rating on Clover Health Investments, Keeps PT at $4.10

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds. On September 8, Canaccord Genuity reiterated the Buy rating on Clover Health Investments, Corp. (NASDAQ:CLOV), keeping the price target at $4.10 Canaccord analyst Richard Close expects Clover Health Investment to benefit from the 2026 Medicare Advantage (MA) rates, which are projected to grow by an average of 9.04%. Along with this growth, the company’s top-rated PPO plan could boost i ...